1a-Docosahexaenoyl mitomycin C

A novel inhibitor of protein tyrosine kinase

Mayumi Shikano, Kenjiro Onimura, Yoshihisa Fukai, Makoto Hori, Hidesuke Fukazawa, Satoshi Mizuno, Kazunaga Yazawa, Yoshimasa Uehara

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A series of derivatives of mitomycin C conjugated with various fatty acids at position la was synthesized and the effect of these compounds on protein kinase activities was evaluated. 1a-Docosahexaenoyl mitomycin C (DMMC) selectively inhibited protein tyrosine kinase (PTK) activity in the postnuclear fraction of v-src-transformed NIH 3T3 cells although neither derivatives conjugated with other fatty acids or docosahexaenoic acid or mitomycin C did not. DMMC inhibited the activity of calmodulin-dependent kinase III and protein kinase A very weakly, and only barely affected protein kinase C activity. DMMC also attenuated autophosphorylation of immunoprecipitated p60(v-)src irreversibly. The addition of thiol compounds to the reaction mixture reversed the inhibition by DMMC, suggesting that some thiol moiety of PTK protein might be involved. DMMC also inhibited kinase activity of p210(bcr-abl) immunoprecipitated from the lysate of K562 cells. These results indicate that DMMC is a novel inhibitor of PTK.

Original languageEnglish
Pages (from-to)858-863
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume248
Issue number3
DOIs
Publication statusPublished - 1998 Jul 30
Externally publishedYes

Fingerprint

Mitomycin
Protein-Tyrosine Kinases
Sulfhydryl Compounds
Oncogene Protein pp60(v-src)
Fatty Acids
Calmodulin
Derivatives
NIH 3T3 Cells
Calcium-Calmodulin-Dependent Protein Kinases
K562 Cells
Docosahexaenoic Acids
Cyclic AMP-Dependent Protein Kinases
1a-docosahexaenoyl mitomycin C
Protein Kinases
Protein Kinase C
Phosphotransferases
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Shikano, M., Onimura, K., Fukai, Y., Hori, M., Fukazawa, H., Mizuno, S., ... Uehara, Y. (1998). 1a-Docosahexaenoyl mitomycin C: A novel inhibitor of protein tyrosine kinase. Biochemical and Biophysical Research Communications, 248(3), 858-863. https://doi.org/10.1006/bbrc.1998.9077

1a-Docosahexaenoyl mitomycin C : A novel inhibitor of protein tyrosine kinase. / Shikano, Mayumi; Onimura, Kenjiro; Fukai, Yoshihisa; Hori, Makoto; Fukazawa, Hidesuke; Mizuno, Satoshi; Yazawa, Kazunaga; Uehara, Yoshimasa.

In: Biochemical and Biophysical Research Communications, Vol. 248, No. 3, 30.07.1998, p. 858-863.

Research output: Contribution to journalArticle

Shikano, M, Onimura, K, Fukai, Y, Hori, M, Fukazawa, H, Mizuno, S, Yazawa, K & Uehara, Y 1998, '1a-Docosahexaenoyl mitomycin C: A novel inhibitor of protein tyrosine kinase', Biochemical and Biophysical Research Communications, vol. 248, no. 3, pp. 858-863. https://doi.org/10.1006/bbrc.1998.9077
Shikano, Mayumi ; Onimura, Kenjiro ; Fukai, Yoshihisa ; Hori, Makoto ; Fukazawa, Hidesuke ; Mizuno, Satoshi ; Yazawa, Kazunaga ; Uehara, Yoshimasa. / 1a-Docosahexaenoyl mitomycin C : A novel inhibitor of protein tyrosine kinase. In: Biochemical and Biophysical Research Communications. 1998 ; Vol. 248, No. 3. pp. 858-863.
@article{9d2ed71265524d1ba7361ce762e83d98,
title = "1a-Docosahexaenoyl mitomycin C: A novel inhibitor of protein tyrosine kinase",
abstract = "A series of derivatives of mitomycin C conjugated with various fatty acids at position la was synthesized and the effect of these compounds on protein kinase activities was evaluated. 1a-Docosahexaenoyl mitomycin C (DMMC) selectively inhibited protein tyrosine kinase (PTK) activity in the postnuclear fraction of v-src-transformed NIH 3T3 cells although neither derivatives conjugated with other fatty acids or docosahexaenoic acid or mitomycin C did not. DMMC inhibited the activity of calmodulin-dependent kinase III and protein kinase A very weakly, and only barely affected protein kinase C activity. DMMC also attenuated autophosphorylation of immunoprecipitated p60(v-)src irreversibly. The addition of thiol compounds to the reaction mixture reversed the inhibition by DMMC, suggesting that some thiol moiety of PTK protein might be involved. DMMC also inhibited kinase activity of p210(bcr-abl) immunoprecipitated from the lysate of K562 cells. These results indicate that DMMC is a novel inhibitor of PTK.",
author = "Mayumi Shikano and Kenjiro Onimura and Yoshihisa Fukai and Makoto Hori and Hidesuke Fukazawa and Satoshi Mizuno and Kazunaga Yazawa and Yoshimasa Uehara",
year = "1998",
month = "7",
day = "30",
doi = "10.1006/bbrc.1998.9077",
language = "English",
volume = "248",
pages = "858--863",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - 1a-Docosahexaenoyl mitomycin C

T2 - A novel inhibitor of protein tyrosine kinase

AU - Shikano, Mayumi

AU - Onimura, Kenjiro

AU - Fukai, Yoshihisa

AU - Hori, Makoto

AU - Fukazawa, Hidesuke

AU - Mizuno, Satoshi

AU - Yazawa, Kazunaga

AU - Uehara, Yoshimasa

PY - 1998/7/30

Y1 - 1998/7/30

N2 - A series of derivatives of mitomycin C conjugated with various fatty acids at position la was synthesized and the effect of these compounds on protein kinase activities was evaluated. 1a-Docosahexaenoyl mitomycin C (DMMC) selectively inhibited protein tyrosine kinase (PTK) activity in the postnuclear fraction of v-src-transformed NIH 3T3 cells although neither derivatives conjugated with other fatty acids or docosahexaenoic acid or mitomycin C did not. DMMC inhibited the activity of calmodulin-dependent kinase III and protein kinase A very weakly, and only barely affected protein kinase C activity. DMMC also attenuated autophosphorylation of immunoprecipitated p60(v-)src irreversibly. The addition of thiol compounds to the reaction mixture reversed the inhibition by DMMC, suggesting that some thiol moiety of PTK protein might be involved. DMMC also inhibited kinase activity of p210(bcr-abl) immunoprecipitated from the lysate of K562 cells. These results indicate that DMMC is a novel inhibitor of PTK.

AB - A series of derivatives of mitomycin C conjugated with various fatty acids at position la was synthesized and the effect of these compounds on protein kinase activities was evaluated. 1a-Docosahexaenoyl mitomycin C (DMMC) selectively inhibited protein tyrosine kinase (PTK) activity in the postnuclear fraction of v-src-transformed NIH 3T3 cells although neither derivatives conjugated with other fatty acids or docosahexaenoic acid or mitomycin C did not. DMMC inhibited the activity of calmodulin-dependent kinase III and protein kinase A very weakly, and only barely affected protein kinase C activity. DMMC also attenuated autophosphorylation of immunoprecipitated p60(v-)src irreversibly. The addition of thiol compounds to the reaction mixture reversed the inhibition by DMMC, suggesting that some thiol moiety of PTK protein might be involved. DMMC also inhibited kinase activity of p210(bcr-abl) immunoprecipitated from the lysate of K562 cells. These results indicate that DMMC is a novel inhibitor of PTK.

UR - http://www.scopus.com/inward/record.url?scp=0032581427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032581427&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1998.9077

DO - 10.1006/bbrc.1998.9077

M3 - Article

VL - 248

SP - 858

EP - 863

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -